CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
A prospective multicenter pilot study to investigate the efficacy of pegylated Interferon-α2b and ribavirin in HBsAg+/HCV-RNA+ patients: The HEP-NET B/C coinfection trial
DOI 10.1055/s-2008-1037654
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Potthoff, H Wedemeyer, WO Boecher, T Berg, S Zeuzem, J Arnold, U Spengler, K Deterding, MP Manns, C Trautwein
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and Patients: HBV/HCV coinfection has been associated with more severe liver disease and a higher risk of hepatocellular carcinoma. Interferon alpha alone or in combination with ribavirin (RBV) can achieve sustained HCV clearance and long-term HBV-DNA suppression. The aim of this prospective multicenter pilot trial was to assess the efficacy of PEG-IFN-α2b and RBV in HBV/HCV coinfected patients. Nineteen…
Zitieren
Zitierempfehlung
A Potthoff, H Wedemeyer, WO Boecher, T Berg, S Zeuzem, J Arnold, U Spengler, K Deterding, MP Manns, C Trautwein (2008) A prospective multicenter pilot study to investigate the efficacy of pegylated Interferon-α2b and ribavirin in HBsAg+/HCV-RNA+ patients: The HEP-NET B/C coinfection trial. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-2008-1037654
Mit CareLit weiterarbeiten